Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
about
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Preventive health measures in inflammatory bowel diseaseHealthcare maintenance in elderly patients with inflammatory bowel disease.Combination therapy for the treatment of Crohn's disease.A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseRisk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease.Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis.Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.Thiopurine Metabolism in the Era of Combotherapy.Management of inflammatory bowel disease in older persons: evolving paradigms.
P2860
Q26777409-1DAA5D52-FEE1-45C3-94FB-E8A33C15BCBFQ28078112-B271AC8C-3D75-426B-A334-62A6647B1C86Q33621700-DE313445-06FE-45AA-9DAC-ECFACE00C215Q35714202-76EE7362-4E03-419D-AC75-F8C0ECA48EB8Q35973766-5C3FCF91-2E8C-4772-AEDF-2472C9082950Q37078107-4FB3F4CC-3607-49DD-8D19-BBEBB42558C2Q38625992-027A9CC5-95A1-4710-B4E1-0BAFE91D7FCDQ38735146-E19C0CE1-EAC8-4587-933C-74FB3A85AB0EQ39783472-9AEFF012-7ED3-4EF2-883D-08055DB174CDQ40383687-7B81930B-A5B8-4601-89F7-E055F5F864BEQ47555158-CBB88246-03F9-488E-894C-F358965D5E2DQ47858365-E49AFAEA-2423-449A-94C7-C545FFBA3961Q48224314-79C7EAF3-2BD7-45F4-9FAC-F8915D6BA9B4Q50691937-CD2A4BBC-649E-4DC4-B328-AA6A9FA0E711Q55214429-F27CCE11-D22E-43BA-B412-72DD34078399
P2860
Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@en
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@nl
type
label
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@en
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@nl
prefLabel
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@en
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@nl
P2093
P2860
P356
P1476
Risk of melanoma and non-melan ...... tionwide retrospective cohort.
@en
P2093
Ali M Abbas
Gary R Lichtenstein
Nabeel Khan
Rawaa M Almukhtar
P2860
P304
P356
10.1038/AJG.2014.298
P407
P577
2014-09-23T00:00:00Z